CXCL12 and B-cell chronic lymphocytic leukemia: However, the chemotaxis of Granta519 towards the combination of 2-AG and CXCL12 was not significantly different from chemotaxis towards CXCL12 alone (p = 0.13), which was also the case for some of the primary samples (MCL and CLL) (Figure S4).